ChizuruYoshida

Associate

Tokyo + 81.3.6800.1815

Connect:

Share

Chizuru Yoshida has experience in international and domestic business transactions and general corporate matters, with a particular focus on Japanese regulatory issues, including those in the life sciences and antitrust sectors.

Experience

  • TotalEnergies' affiliate Cray Valley sells three product lines to Pacific Avenue Capital PartnersJones Day is advising Total Energies on its sale of three product lines to Pacific Avenue Capital Partners (Wingtack®, PolyBD® and Dymalink®) developed by Cray Valley, its resin production and sales affiliate.
  • JENSEN-GROUP and MIURA create heavy-duty laundry joint venture in JapanJones Day advised JENSEN-GROUP in the formation of a joint venture with MIURA whereby the JENSEN-GROUP acquired 49% of the shares of Inax Corporation, one of the main manufacturing and distribution companies for heavy-duty laundry equipment in Japan and a Japanese wholly owned subsidiary of MIURA, and MIURA took a 20% stake in the JENSEN-GROUP through a combination of 49% of the shares of Inax and an add-on capital increase in cash.
  • IMCD acquires Kuni ChemicalJones Day advised IMCD N.V. in the acquisition by subsidiary IMCD Japan of 100% of the shares of the speciality distribution company, Kuni Chemical Co., Ltd. from Japan Private Equity Co., Ltd.
  • CTC takes additional stake in MegazoneJones Day advised Itochu Corporation subsidiary, ITOCHU Techno-Solutions Corporation ("CTC"), in the additional acquisition of a 30% stake in Megazone Corporation for the purpose of strongly promoting the joint venture business.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • OMRON invests in Taiwan’s collaborative robot company Techman Robot Inc.Jones Day advised Omron Corporation in its capital investment in Techman Robot, Inc., the world's second-largest collaborative robot brand that work with people at manufacturing sites.
  • SAP forms strategic partnership with Dediq for financial services industriesJones Day advised SAP in the formation of SAP Fioneer, a joint venture with the Munich based investor DEDIQ GmbH whereby SAP contributed its Financial Services and Insurance Services business and DEDIQ will invest more than €500 million.
  • ETS acquires TOEFL® assets of Council on International Educational Exchange (CIEE)-JapanJones Day advised ETS in the acquisition of the TOEFL® assets of the Council on International Educational Exchange (CIEE)-Japan.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
    • View All

    April 2023 ニュースレター

    Global Legal Update Vol. 90 | 2023年4月号

    March 2023 ニュースレター

    Global Legal Update Vol. 89 | 2023年3月号

    February 2023 ニュースレター

    Global Legal Update Vol. 88 | 2023年2月号

    January 2023 ニュースレター

    Global Legal Update Vol. 87 | 2023年1月号

    December 2022 ニュースレター

    Global Legal Update Vol. 86 | 2022年12月号

    November 2022 ニュースレター

    Global Legal Update Vol. 85 | 2022年11月号

    October 2022 ニュースレター

    Global Legal Update Vol. 84 | 2022年10月号

    September 2022 ニュースレター

    Global Legal Update Vol. 83 | 2022年9月号

    August 2022 ニュースレター

    Global Legal Update Vol. 82 | 2022年8月号

    July 2022 ニュースレター

    Global Legal Update Vol. 81 | 2022年7月号
    View All

    Additional Publications

    • March 2023
      Law and Practice Japan, Pharmaceutical Advertising 2023, Chambers Global Practice Guides
    • March 2022
      Law and Practice Japan, Pharmaceutical Advertising 2022, Chambers Global Practice Guides

    Speaking Engagements

    • August 2022
      HR Policy Association: Gender Pay Gap Disclosure Japan

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.